Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the December 24, 2014, Federal Register, FDA announced that it has extended the comment period regarding the Agency's implementation of the Rare Pediatric Disease Priority Review Vouchers Program.
United StatesFood, Drugs, Healthcare, Life Sciences
In the December 24, 2014, Federal Register,
FDA announced that it has extended the comment period regarding the
Agency's implementation of the Rare Pediatric Disease Priority
Review Vouchers Program. Comments now due February 16,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.